High-quality products
Reliable performance
Crizotinib is a type of targeted cancer drug. It is also known as Xalkori. It is a treatment for advanced non small cell lung cancer (NSCLC). Crizotinib is for NSCLC that has changes in either a gene called anaplastic lymphoma kinase (ALK) or ROS1.
High-quality products
Reliable performance
Wide range of applications
For various laboratory needs
Expert support
Professional service team
Fast delivery
Global shipping